Travere Therapeutics
TVTX
TVTX
111 hedge funds and large institutions have $710M invested in Travere Therapeutics in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 53 increasing their positions, 31 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
23% less call options, than puts
Call options by funds: $28.5M | Put options by funds: $36.7M
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
Holders
111
Holding in Top 10
6
Calls
$28.5M
Puts
$36.7M
Top Buyers
| 1 | +$23.8M | |
| 2 | +$13.7M | |
| 3 | +$9.8M | |
| 4 |
Millennium Management
New York
|
+$7.72M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.48M |
Top Sellers
| 1 | -$14M | |
| 2 | -$5.29M | |
| 3 | -$4.99M | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$3.51M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$2.92M |